Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 19902015: a systematic analysis for the global burden of disease study 2015
Giustarini D et al
Two patients on identical medications can have very different outcomes based on adherence alone
But, if left undetected, melanoma can spread to distant sites or organs
This guide covers every major GLP-1 drug pipeline candidate worth watching in 2026: the compounds already approved, the assets awaiting regulatory decisions, and the emerging molecules that could define the next decade of metabolic medicine
Because retatrutide is investigational, any adjustment to the dose-escalation schedule must be directed by the prescribing clinician or trial team patients should not alter their dosing independently